| Secondary |
| Rheumatoid Arthritis |
30.4% |
| Prophylaxis |
9.6% |
| Psoriasis |
9.5% |
| Product Used For Unknown Indication |
6.9% |
| Drug Use For Unknown Indication |
5.9% |
| Antibiotic Prophylaxis |
5.1% |
| Pneumonia |
4.8% |
| Lymph Node Tuberculosis |
4.6% |
| Pulmonary Tuberculosis |
3.3% |
| Hypertension |
3.2% |
| Hiv Infection |
2.4% |
| Behcet's Syndrome |
1.9% |
| Osteoporosis |
1.9% |
| Tuberculous Pleurisy |
1.7% |
| Bronchopulmonary Aspergillosis |
1.5% |
| Epilepsy |
1.5% |
| Mycobacterium Avium Complex Infection |
1.5% |
| Psoriatic Arthropathy |
1.5% |
| Renal Transplant |
1.3% |
| Tuberculosis |
1.3% |
|
| Hepatic Function Abnormal |
12.9% |
| Sepsis |
12.1% |
| Liver Disorder |
10.7% |
| Hepatorenal Syndrome |
5.7% |
| Rash |
5.0% |
| Vomiting |
5.0% |
| Pneumocystis Jiroveci Pneumonia |
4.3% |
| Quadriplegia |
4.3% |
| Renal Disorder |
4.3% |
| White Blood Cell Count Decreased |
4.3% |
| Agranulocytosis |
3.6% |
| Pyrexia |
3.6% |
| Renal Failure |
3.6% |
| Spinal Fracture |
3.6% |
| Blood Creatine Phosphokinase Increased |
2.9% |
| Hepatic Failure |
2.9% |
| Hepatitis Acute |
2.9% |
| Interstitial Lung Disease |
2.9% |
| Mycobacterium Avium Complex Infection |
2.9% |
| Pulmonary Tuberculosis |
2.9% |
|
| Concomitant |
| Rheumatoid Arthritis |
50.2% |
| Prophylaxis |
10.5% |
| Antibiotic Prophylaxis |
7.6% |
| Drug Use For Unknown Indication |
4.9% |
| Hypertension |
4.2% |
| Psoriasis |
4.1% |
| Osteoporosis |
3.7% |
| Gastritis |
1.8% |
| Tuberculosis |
1.4% |
| Insomnia |
1.3% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.3% |
| Gastric Ulcer |
1.2% |
| Product Used For Unknown Indication |
1.2% |
| Constipation |
1.1% |
| Reflux Oesophagitis |
1.0% |
| Colitis Ulcerative |
1.0% |
| Diabetes Mellitus |
0.9% |
| Osteoporosis Prophylaxis |
0.9% |
| Crohn's Disease |
0.9% |
| Gastrointestinal Disorder Therapy |
0.8% |
|
| Pneumocystis Jiroveci Pneumonia |
16.4% |
| Interstitial Lung Disease |
11.8% |
| Pneumonia |
7.0% |
| Pyrexia |
6.5% |
| Urinary Tract Infection |
5.5% |
| White Blood Cell Count Decreased |
5.3% |
| Respiratory Failure |
4.6% |
| Sepsis |
4.3% |
| Breast Cancer |
3.9% |
| Rash |
3.9% |
| Liver Disorder |
3.6% |
| Rheumatoid Arthritis |
3.6% |
| Stomatitis |
3.6% |
| Melaena |
3.4% |
| Pulmonary Tuberculosis |
3.4% |
| Renal Disorder |
2.9% |
| Renal Impairment |
2.7% |
| Tuberculosis |
2.7% |
| Vomiting |
2.7% |
| Pemphigoid |
2.4% |
|
| Interacting |
| Disseminated Tuberculosis |
44.3% |
| Hypertension |
18.3% |
| Tuberculous Pleurisy |
7.6% |
| Tuberculosis |
6.9% |
| Pain |
3.1% |
| Pyrexia |
3.1% |
| Ear Tuberculosis |
2.3% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.3% |
| Renal Cell Carcinoma Stage Iv |
2.3% |
| Cardiac Failure |
1.5% |
| Constipation |
1.5% |
| Diabetes Mellitus |
1.5% |
| Gastritis |
1.5% |
| Langerhans' Cell Histiocytosis |
1.5% |
| Prophylaxis |
1.5% |
| Infection Prophylaxis |
0.8% |
|
| Hypertensive Encephalopathy |
44.4% |
| Hepatic Failure |
22.2% |
| Tuberculosis |
16.7% |
| Hepatitis Fulminant |
11.1% |
| White Blood Cell Count Increased |
5.6% |
|
